ScienceDaily: Latest Science News |
| Antibody-based drug helps 'bridge' leukemia patients to curative treatment Posted: 12 Jun 2016 07:58 AM PDT In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants. |
| You are subscribed to email updates from Latest Science News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment